Bio‐marker detection redundancy improves sensitivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bio‐marker detection redundancy improves sensitivity

Published:2022-05 Issue:2 Volume:2 Page:
ISSN:2768-0622
Container-title:Clinical and Translational Discovery
language:en
Short-container-title:Clinical and Translational Dis

Author:

Clanchy Felix IL¹²^ORCID

Affiliation:

1. Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences University of Oxford, Roosevelt Drive Oxford UK

2. Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences University of Oxford Oxford UK

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctd2.62

Reference10 articles.

1. A case of cancer in which cells similar to those in the tumours were seen in the blood after death;Ashworth TR;Aust Med J,1869

2. Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer

3. TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

4. Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma

5. The usefulness of lactate dehydrogenase measurements in current oncological practice

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP